Core Insights - The article discusses the increasing trend of banks promoting insurance products, driven by the ongoing "deposit migration" and the urgent need for banks to boost their intermediary business revenue [2][6] - The insurance industry is witnessing a competitive landscape in the bancassurance channel, with significant growth in premium income, particularly among leading insurance companies [3][6] Group 1: Industry Trends - In 2025, the bancassurance channel for life insurance is expected to see an overall premium growth rate of approximately 10%, with leading insurers outperforming the industry average [3] - The "old seven" life insurance companies (including Ping An Life and China Life) achieved over 40% growth in bancassurance premiums, with Ping An Life leading at a remarkable 163% year-on-year increase [3][6] - The total premium income of the insurance industry surpassed 6 trillion yuan in 2025, marking a 7.4% year-on-year growth, with life insurance companies contributing significantly [6] Group 2: Competitive Landscape - There is a clear division among bank-affiliated insurance companies, with some experiencing significant growth while others face declines; for instance, Everbright Life Insurance saw a 111% increase, while others like China Merchants Life faced negative growth [4][5] - Foreign and joint venture insurers, although smaller in size, are achieving impressive growth rates by focusing on high-net-worth clients and long-term value services [5] Group 3: Strategic Developments - The removal of restrictions on the number of insurance companies a single bank branch can partner with has expanded product selection and improved matching with customer needs [7] - Insurers are actively enhancing their bancassurance channel strategies, with predictions indicating that new business value growth will be primarily driven by this channel in 2026 [8][11] - Major insurers are establishing extensive partnerships with banks, with China Life collaborating with over 100 banks and other companies also expanding their banking partnerships [9][11]

证券研究报告 | 行业点评 gszqdatemark 2026 02 05 年 月 日 保险：资负共振，寿险景气度提升新周期确立。1）资产端：长端利率企 稳、资本市场稳中向好，保险投资端全面向好，具备业绩弹性，且头部公 司利差损风险大幅缓解释放估值修复空间。2）负债端：开门红表现为全 年新单奠定良好基调，有望提振 2026 年负债端整体表现，寿险行业长期 持续受益于银行存款搬家趋势，除银行存款外，保险也是具备刚性兑付特 征的金融产品。多元化的理财储蓄、医疗、养老等保险需求将推动行业持 续扩容。随着头部险企产品结构转向分红险，投资环境的向好进一步提升 保险产品的竞争力，实现资产负债两端正向循环。 券商：慢牛环境下，基本面与估值严重错配，配置性价比高。2025 年全年 A 股市场股基日均成交额 2.08 万亿，同比增长 70.36%；IPO 审核通过家 数同比大增 109.43%，募资金额增长 208.01%；全年上证指数上涨 18.41%、沪深 300 指数上涨 17.66%、创业板指上涨 49.57%。已发布业 绩预告的上市券商合计归母净利润同比增长约 60%左右，头部券商稳健 增长，部分中小券商业绩弹性凸显 ...

证券研究报告 | 行业点评 gszqdatemark 2026 02 05 年 月 日 非银板块整体业绩与估值均具备强 beta 属性，全面看好非银板块。 保险：资负共振，寿险景气度提升新周期确立。1）资产端：长端利率企 稳、资本市场稳中向好，保险投资端全面向好，具备业绩弹性，且头部公 司利差损风险大幅缓解释放估值修复空间。2）负债端：开门红表现为全 年新单奠定良好基调，有望提振 2026 年负债端整体表现，寿险行业长期 持续受益于银行存款搬家趋势，除银行存款外，保险也是具备刚性兑付特 征的金融产品。多元化的理财储蓄、医疗、养老等保险需求将推动行业持 续扩容。随着头部险企产品结构转向分红险，投资环境的向好进一步提升 保险产品的竞争力，实现资产负债两端正向循环。 券商：慢牛环境下，基本面与估值严重错配，配置性价比高。2025 年全年 A 股市场股基日均成交额 2.08 万亿，同比增长 70.36%；IPO 审核通过家 数同比大增 109.43%，募资金额增长 208.01%；全年上证指数上涨 18.41%、沪深 300 指数上涨 17.66%、创业板指上涨 49.57%。已发布业 绩预告的上市券商合计归母净利润 ...

Group 1: Insurance Sector - Insurance stocks are experiencing significant declines, with China Life (02628) down 3.75%, New China Life (01336) down 3.28%, and China Pacific Insurance (02601) down 2.74%. The government plans to issue approximately 200 billion yuan in special bonds to inject capital into major insurance companies, marking the first time this method will be used for insurance firms in China [1] Group 2: Logistics and Delivery - ZTO Express (02057) has seen an increase of over 2.3%. The company estimates that its total revenue for 2025 will be between 48.5 billion yuan and 50 billion yuan, representing a growth of approximately 9.5% to 12.9% compared to 44.2807 billion yuan in 2024 [1] Group 3: Biotechnology - Innovent Biologics (09969) has risen over 4%, with a current increase of 3.25%. The company anticipates achieving revenue of 2.37 billion yuan in 2025, a year-on-year growth of approximately 134%, and expects to turn a profit with a net profit of around 630 million yuan [1] Group 4: Coal Sector - Coal stocks are generally declining, with Yancoal Australia (03668) down 6.63%, Shougang Resources (00639) down 7.83%, and China Shenhua (01088) down 2.47%. This decline follows reports that the Indonesian government has proposed a production cut plan, leading to a 40% to 70% reduction in production quotas for major miners [2] Group 5: Medical Devices - GigaGen (02367) has increased over 8%, currently up 4.11%. The company recently announced that its "recombinant type I α1 collagen and sodium hyaluronate composite solution" has been approved as a medical device, marking a significant milestone as the first product of its kind for improving facial smoothness [2] Group 6: Semiconductor Sector - Semiconductor stocks are all declining, with Hua Hong Semiconductor (01347) down 5.91% and SMIC (00981) down 3.49%. This follows a significant drop in AMD's stock price by 17.31% after its fourth-quarter report indicated that while revenue exceeded expectations, the guidance for the first quarter was below market expectations [3] Group 7: Restaurant Sector - Restaurant stocks are performing well, with Yum China (09987) up 8.41% and Haidilao (06862) up 2.69%. The restaurant industry has shown signs of recovery, with retail sales in the sector growing by 3.8%, 3.2%, and 2.2% year-on-year in the last quarter of 2025, significantly outpacing overall retail growth [3] Group 8: Consumer Goods - Miniso (09896) has risen over 5.1% after announcing its partnership with the Central Radio and Television Station for the 2026 Spring Festival Gala. This collaboration is seen as a significant marketing move to elevate the brand's visibility in the mainstream market [4] Group 9: Gold Sector - Gold stocks are declining, with China Gold International (02099) down 6.8% and Zijin Mining (02899) down 6.29%. Recent volatility in the international gold market has been noted, with expectations that geopolitical tensions and liquidity easing by the Federal Reserve may drive gold prices higher [4] Group 10: Cryptocurrency - Cryptocurrency ETFs and related stocks are continuing to decline, with significant drops in prices, including Bitcoin falling below $72,000 for the first time in 15 months. The price has decreased by over 42% from its peak last October [5] Group 11: US Market Highlights - Boston Scientific (BSX.US) fell 17.59% after providing lower-than-expected guidance for fiscal year 2026. The company expects adjusted earnings per share to be between $3.43 and $3.49, slightly below analyst expectations [6] - Solar stocks surged, with Enphase Energy (ENPH.US) rising 38.6% following reports of interest from Elon Musk's teams in the Chinese solar supply chain [6]

二、新华人寿保险股份有限公司应按照有关规定及时办理变更及许可证换领事宜。 2026年2月4日，国家金融监督管理总局甘南监管分局发布批复称，《新华人寿保险股份有限公司甘肃分 公司关于甘南中心支公司营业场所变更的请示》(新保甘字〔2026〕9号)材料收悉。经审核，现批复如 下： 一、同意新华人寿保险股份有限公司甘南中心支公司将营业场所变更为：甘肃省甘南州合作市美森佳苑 保障性住宅小区15#楼二楼1号商铺。 ...

Group 1 - Hong Kong insurance stocks experienced significant declines, with China Life Insurance (02628.HK) falling by 3.81% to HKD 33.82 [1] - New China Life Insurance (01336.HK) decreased by 3.6%, trading at HKD 60.2 [1] - China Pacific Insurance (02601.HK) saw a drop of 3.14%, with shares priced at HKD 38.24 [1]

Core Viewpoint - The insurance stocks have experienced significant declines, with major companies like China Life, New China Life, and China Pacific Insurance seeing drops of 3.81%, 3.6%, and 3.14% respectively. The government is planning to issue approximately 200 billion yuan in special bonds to inject capital into large insurance firms, marking a potential first for such a move in China [1]. Group 1: Stock Performance - China Life (601628) shares fell by 3.81%, trading at 33.82 HKD [1] - New China Life (601336) shares decreased by 3.6%, trading at 60.2 HKD [1] - China Pacific Insurance (601601) shares dropped by 3.14%, trading at 38.24 HKD [1] Group 2: Government Action - The government plans to issue around 200 billion yuan in special bonds to provide capital to state-owned insurance companies like China Life and PICC [1] - This initiative could be announced as early as the first quarter of this year [1] - It represents a potential first for the issuance of special bonds aimed at injecting capital into insurance firms in China [1] Group 3: Industry Analysis - According to Industrial Securities, leading state-owned insurance companies require additional capital due to the lagging nature of the 750-day curve used in calculating reserves [1] - The 750-day curve is expected to continue declining, which will further pressure solvency despite interest rates remaining stable [1] - The recent increase in equity allocation by insurance companies is likely to exacerbate existing solvency pressures, indicating that the industry faces ongoing challenges [1] - From a regulatory perspective, the capital injection may aim to mitigate tail risks within the industry [1]

Group 1 - The insurance stocks have experienced significant declines, with China Life falling by 3.81% to HKD 33.82, Xinhua Insurance down by 3.6% to HKD 60.2, and China Pacific Insurance decreasing by 3.14% to HKD 38.24 [1] - The government plans to issue approximately CNY 200 billion in special bonds to inject capital into major insurance companies, including China Life and PICC, marking the first time special bonds will be used for this purpose [1] - According to Industrial Securities, there is a pressing need for capital supplementation among leading state-owned insurance companies due to the downward trend in the solvency system, which is expected to continue affecting solvency levels in the coming years [1] Group 2 - The solvency pressure in the insurance industry is exacerbated by the increased allocation of equities, which further strains already tight solvency conditions [1] - From a regulatory perspective, the capital injection may aim to mitigate tail risks within the industry [1]

2月2日，中國人壽（02628）全日收報33.50元，較前一交易日下跌3.96%，成交量37.37億元，整體走勢隨保險板塊同步調整，未出現異常量能變化。從價格 定位來看，股價剛好站在10日均線（33.50元）位置，形成短期平衡點，同時明顯高於30日均線（31.28元）和60日均線（29.17元），中長期均線仍呈現弱多 排列，下方有一定支撐力度。 RSI指標為60，處於50-70的中立區間，既未進入超買（≥70）也未達到超賣（≤30），說明當前多空博弈相對均衡，沒有明顯的一方佔優局面；威廉指標、隨 機震盪指標、CCI指標均給出中立信號，進一步印證短期震盪格局。MACD信號為買入，但技術指標總結信號為中立（信號強度10），主要原因是個股短期 調整與中長期均線支撐形成矛盾，暫未形成明確趨勢方向；多條移動平均線信號為賣出，與單個均線支撐並不衝突，反映短期走勢偏弱。 2月2日，保險板塊個股普遍表現疲軟，與中國人壽走勢保持一致，屬於板塊性調整，而非個股獨立走弱： 從技術信號來看，這些保險股多數為「中立」信號，僅中國太平RSI值達71，給出「賣出」信號，整體板塊承受一定下行壓力，市場情緒偏謹慎。 截至今日（3日）上午10點 ...

Investment Rating - The report provides a "Buy" rating for several key stocks in the financial and manufacturing sectors, including China Resources Land and Beike-W [15][18][20][21]. Core Insights - The macroeconomic environment shows a continuation of strong supply and weak demand characteristics, with short-term growth pressure remaining manageable [9]. - The real estate sector is experiencing a valuation recovery opportunity for quality developers due to a resonance between fundamentals and policies [10]. - The banking sector is witnessing a recovery from oversold conditions, with stock prices rebounding ahead of improvements in the funding environment [20]. - The non-bank financial sector is expected to benefit from policy-driven high-quality development, with a focus on high-performing stocks [22]. - The new energy sector has established a bottom line, with attention on marginal changes in new technologies [25]. - The machinery sector is gaining order resilience from overseas solar expansion and new business developments, while space solar technology opens growth opportunities [31]. - The environmental sector is focusing on carbon neutrality opportunities, with overseas expansion and metal prices providing elasticity [33]. Summary by Sections Real Estate - The sector is expected to face challenges in 2026, but recent policy easing and improved second-hand housing sales indicate a potential recovery [14]. - China Resources Land is highlighted as a leading developer with strong operational capabilities and a solid financial position, projected to achieve a net profit of 26.2 billion, 27 billion, and 28.2 billion from 2025 to 2027 [15]. Banking - Nanjing Bank is recommended due to its expected double-digit revenue growth in 2025, driven by stable asset quality and improved net interest margins [21]. Non-Bank Financials - New China Life Insurance is noted for its high elasticity and potential for improved returns on equity, with projected intrinsic values of 292.1 billion and 329.0 billion for 2025 and 2026, respectively [24]. New Energy - The storage sector is expected to see demand stability supported by national capacity pricing, while lithium battery technology is anticipated to rebound with improved economic conditions [25]. - JunDa Co. is recognized for its strategic partnerships and potential growth in the space solar sector, with projected profits increasing significantly by 2027 [27]. Machinery - The machinery sector is benefiting from overseas solar project expansions, with companies like DiEr Laser positioned to capitalize on new technologies and increased order volumes [31][32]. Environmental - Weiming Environmental is highlighted for its potential in the Indonesian waste-to-energy market, with expected project launches in early 2026 [39]. - The company is projected to achieve net profits of 2.88 billion and 3.44 billion in 2025 and 2026, respectively [39]. Light Industry - The light industry is seeing a rebound in export-driven companies, with a focus on quality stocks that can leverage cost efficiencies and supply chain advantages [43]. Military Industry - The military sector is expected to benefit from the transition of military technology to civilian applications and increased military trade, with key recommendations including Aviation Power and AVIC Xi'an Aircraft Industry [51][53].